Matches in Nanopublications for { ?s ?p "[We apply this paradigm to study mesothelin (MSLN) overexpression, a nearly ubiquitous, diagnostically and therapeutically useful characteristic of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP475848.RA7SVIwltveukn18D9RU_gX9BWrM9syk9h0K1k9L87ee8130_assertion description "[We apply this paradigm to study mesothelin (MSLN) overexpression, a nearly ubiquitous, diagnostically and therapeutically useful characteristic of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP475848.RA7SVIwltveukn18D9RU_gX9BWrM9syk9h0K1k9L87ee8130_provenance.
- NP410626.RA3FbQQvk6j9XNCuvbYgQYttFekgnmjtpZIz0H0zXNxWI130_assertion description "[We apply this paradigm to study mesothelin (MSLN) overexpression, a nearly ubiquitous, diagnostically and therapeutically useful characteristic of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP410626.RA3FbQQvk6j9XNCuvbYgQYttFekgnmjtpZIz0H0zXNxWI130_provenance.
- assertion description "[We apply this paradigm to study mesothelin (MSLN) overexpression, a nearly ubiquitous, diagnostically and therapeutically useful characteristic of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We apply this paradigm to study mesothelin (MSLN) overexpression, a nearly ubiquitous, diagnostically and therapeutically useful characteristic of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP632810.RAeQGhKFLdidOY4M83m6Scs-hiQMXAISIpHZCH6ix_uWE130_assertion description "[We apply this paradigm to study mesothelin (MSLN) overexpression, a nearly ubiquitous, diagnostically and therapeutically useful characteristic of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP632810.RAeQGhKFLdidOY4M83m6Scs-hiQMXAISIpHZCH6ix_uWE130_provenance.
- NP632811.RAK2IWXtK9SWFifFN-Cp7yn9VYi0Cv0_wbrOTg4tA2kko130_assertion description "[We apply this paradigm to study mesothelin (MSLN) overexpression, a nearly ubiquitous, diagnostically and therapeutically useful characteristic of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP632811.RAK2IWXtK9SWFifFN-Cp7yn9VYi0Cv0_wbrOTg4tA2kko130_provenance.